This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chang, B.-D. Articles by Roninson, I. B. Search for Related Content PubMed PubMed Citation Articles by Chang, B.-D. Articles by Roninson, I. B.

A Senescence-like Phenotype Distinguishes Tumor Cells That Undergo Terminal Proliferation Arrest after Exposure to Anticancer Agents¹

Departments of Molecular Genetics [B-D. C., E. V. B., M. D., H. Z., A. R., Y. X., E. S. K., E. L., I. B. R.] and Surgical Oncology [K. C.], University of Illinois at Chicago, Chicago, Illinois 60607-7170

Exposure of human tumor cell lines to different chemotherapeutic drugs, ionizing radiation, and differentiating agents induced morphological, enzymatic, and ploidy changes resembling replicative senescence of normal cells. Moderate doses of doxorubicin induced this senescence-like phenotype (SLP) in 11 of 14 tested cell lines derived from different types of human solid tumors, including all of the lines with wild-type p53 and half of p53-mutated cell lines. SLP induction seemed to be independent from mitotic cell death, the other major effect of drug treatment. Among cells that survived drug exposure, SLP markers distinguished those cells that became terminally growth-arrested within a small number of cell divisions from the cells that recovered and resumed proliferation. SLP induction in breast carcinoma cells treated with retinoids in vitro or in vivo was found to correlate with permanent growth inhibition under the conditions of minimal cytotoxicity, suggesting that this response may be particularly important for the antiproliferative effect of differentiating agents. The senescence-like program of terminal proliferation arrest may provide an important determinant of treatment outcome and a target for augmentation in cancer therapy.

This article has been cited by other articles:

				R. Sullivan, G. C. Pare, L. J. Frederiksen, G. L. Semenza, and C. H. Graham Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity Mol. Cancer Ther., July 1, 2008; 7(7): 1961 - 1973. [Abstract] [Full Text] [PDF]

				C. A Schmitt In vivo Complexities of Cellular Senescence in Tumor Development and Therapy Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 499 - 504. [Abstract] [Full Text] [PDF]

				J. Campisi Protumorigenic Effects of the Senescence-Associated Secretory Phenotype Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 505 - 509. [Abstract] [Full Text] [PDF]

				E. Crescenzi, G. Palumbo, J. de Boer, and H. J.M. Brady Ataxia Telangiectasia Mutated and p21CIP1 Modulate Cell Survival of Drug-Induced Senescent Tumor Cells: Implications for Chemotherapy Clin. Cancer Res., March 15, 2008; 14(6): 1877 - 1887. [Abstract] [Full Text] [PDF]

				Y. Qian, J. Zhang, B. Yan, and X. Chen DEC1, a Basic Helix-Loop-Helix Transcription Factor and a Novel Target Gene of the p53 Family, Mediates p53-dependent Premature Senescence J. Biol. Chem., February 1, 2008; 283(5): 2896 - 2905. [Abstract] [Full Text] [PDF]

				C. O'Callaghan-Sunol, V. L. Gabai, and M. Y. Sherman Hsp27 Modulates p53 Signaling and Suppresses Cellular Senescence Cancer Res., December 15, 2007; 67(24): 11779 - 11788. [Abstract] [Full Text] [PDF]

				J. R. Pietruska and A. B. Kane SV40 Oncoproteins Enhance Asbestos-Induced DNA Double-Strand Breaks and Abrogate Senescence in Murine Mesothelial Cells Cancer Res., April 15, 2007; 67(8): 3637 - 3645. [Abstract] [Full Text] [PDF]

				D. Liu and P. J. Hornsby Senescent Human Fibroblasts Increase the Early Growth of Xenograft Tumors via Matrix Metalloproteinase Secretion Cancer Res., April 1, 2007; 67(7): 3117 - 3126. [Abstract] [Full Text] [PDF]

				C. Park, I. Lee, and W. K. Kang Influence of small interfering RNA corresponding to ets homologous factor on senescence-associated modulation of prostate carcinogenesis Mol. Cancer Ther., December 1, 2006; 5(12): 3191 - 3196. [Abstract] [Full Text] [PDF]

				S.-J. Cozzi, P. G. Parsons, S. M. Ogbourne, J. Pedley, and G. M. Boyle Induction of Senescence in Diterpene Ester-Treated Melanoma Cells via Protein Kinase C-Dependent Hyperactivation of the Mitogen-Activated Protein Kinase Pathway. Cancer Res., October 15, 2006; 66(20): 10083 - 10091. [Abstract] [Full Text] [PDF]

				Y. Chen, M. Dokmanovic, W. D. Stein, R. J. Ardecky, and I. B. Roninson Agonist and Antagonist of Retinoic Acid Receptors Cause Similar Changes in Gene Expression and Induce Senescence-like Growth Arrest in MCF-7 Breast Carcinoma Cells. Cancer Res., September 1, 2006; 66(17): 8749 - 8761. [Abstract] [Full Text] [PDF]

				S. Rastogi, B. Joshi, P. Dasgupta, M. Morris, K. Wright, and S. Chellappan Prohibitin Facilitates Cellular Senescence by Recruiting Specific Corepressors To Inhibit E2F Target Genes. Mol. Cell. Biol., June 1, 2006; 26(11): 4161 - 4171. [Abstract] [Full Text] [PDF]

				J. G. Jackson and O. M. Pereira-Smith Primary and Compensatory Roles for RB Family Members at Cell Cycle Gene Promoters That Are Deacetylated and Downregulated in Doxorubicin-Induced Senescence of Breast Cancer Cells. Mol. Cell. Biol., April 1, 2006; 26(7): 2501 - 2510. [Abstract] [Full Text] [PDF]

				M. Braig and C. A. Schmitt Oncogene-induced senescence: putting the brakes on tumor development. Cancer Res., March 15, 2006; 66(6): 2881 - 2884. [Abstract] [Full Text] [PDF]

				T. Tchenio, M. Havard, L. A. Martinez, and F. Dautry Heat Shock-Independent Induction of Multidrug Resistance by Heat Shock Factor 1 Mol. Cell. Biol., January 15, 2006; 26(2): 580 - 591. [Abstract] [Full Text] [PDF]

				C. Bavik, I. Coleman, J. P. Dean, B. Knudsen, S. Plymate, and P. S. Nelson The Gene Expression Program of Prostate Fibroblast Senescence Modulates Neoplastic Epithelial Cell Proliferation through Paracrine Mechanisms Cancer Res., January 15, 2006; 66(2): 794 - 802. [Abstract] [Full Text] [PDF]

				C. M. Lee, C. B. Fuhrman, V. Planelles, M. R. Peltier, D. K. Gaffney, A. P. Soisson, M. K. Dodson, H. D. Tolley, C. L. Green, and K. A. Zempolich Phosphatidylinositol 3-Kinase Inhibition by LY294002 Radiosensitizes Human Cervical Cancer Cell Lines Clin. Cancer Res., January 1, 2006; 12(1): 250 - 256. [Abstract] [Full Text] [PDF]

				E. Crescenzi, G. Palumbo, and H. J.M. Brady Roscovitine Modulates DNA Repair and Senescence: Implications for Combination Chemotherapy Clin. Cancer Res., November 15, 2005; 11(22): 8158 - 8171. [Abstract] [Full Text] [PDF]

				A. Vigneron, I. B. Roninson, E. Gamelin, and O. Coqueret Src Inhibits Adriamycin-Induced Senescence and G2 Checkpoint Arrest by Blocking the Induction of p21waf1 Cancer Res., October 1, 2005; 65(19): 8927 - 8935. [Abstract] [Full Text] [PDF]

				D. L. Morse, H. Gray, C. M. Payne, and R. J. Gillies Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells Mol. Cancer Ther., October 1, 2005; 4(10): 1495 - 1504. [Abstract] [Full Text] [PDF]

				W.-S. Xu, G. Perez, L. Ngo, C.-Y. Gui, and P. A. Marks Induction of Polyploidy by Histone Deacetylase Inhibitor: A Pathway for Antitumor Effects Cancer Res., September 1, 2005; 65(17): 7832 - 7839. [Abstract] [Full Text] [PDF]

				Y. Tu, D. J. Jerry, B. Pazik, and S. Smith Schneider Sensitivity to DNA Damage Is a Common Component of Hormone-Based Strategies for Protection of the Mammary Gland Mol. Cancer Res., August 1, 2005; 3(8): 435 - 442. [Abstract] [Full Text] [PDF]

				R. S. Roberson, S. J. Kussick, E. Vallieres, S.-Y. J. Chen, and D. Y. Wu Escape from Therapy-Induced Accelerated Cellular Senescence in p53-Null Lung Cancer Cells and in Human Lung Cancers Cancer Res., April 1, 2005; 65(7): 2795 - 2803. [Abstract] [Full Text] [PDF]

				X. Huang, T. Tran, L. Zhang, R. Hatcher, and P. Zhang DNA damage-induced mitotic catastrophe is mediated by the Chk1-dependent mitotic exit DNA damage checkpoint PNAS, January 25, 2005; 102(4): 1065 - 1070. [Abstract] [Full Text] [PDF]

				B. J. Nickoloff, M. W. Lingen, B.-D. Chang, M. Shen, M. Swift, J. Curry, P. Bacon, B. Bodner, and I. B. Roninson Tumor Suppressor Maspin Is Up-Regulated during Keratinocyte Senescence, Exerting a Paracrine Antiangiogenic Activity Cancer Res., May 1, 2004; 64(9): 2956 - 2961. [Abstract] [Full Text] [PDF]

				B. B.Y. Ma, R. G. Bristow, J. Kim, and L. L. Siu Combined-Modality Treatment of Solid Tumors Using Radiotherapy and Molecular Targeted Agents J. Clin. Oncol., July 15, 2003; 21(14): 2760 - 2776. [Abstract] [Full Text] [PDF]

				I. B. Roninson Tumor Cell Senescence in Cancer Treatment Cancer Res., June 1, 2003; 63(11): 2705 - 2715. [Abstract] [Full Text] [PDF]

				L. W. Elmore, C. W. Rehder, X. Di, P. A. McChesney, C. K. Jackson-Cook, D. A. Gewirtz, and S. E. Holt Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction J. Biol. Chem., September 13, 2002; 277(38): 35509 - 35515. [Abstract] [Full Text] [PDF]

				R. Haq, J. D. Brenton, M. Takahashi, D. Finan, R. Rottapel, and B. Zanke Constitutive p38HOG Mitogen-activated Protein Kinase Activation Induces Permanent Cell Cycle Arrest and Senescence Cancer Res., September 1, 2002; 62(17): 5076 - 5082. [Abstract] [Full Text] [PDF]

				T. M. Kiviharju, P. S. Lecane, R. G. Sellers, and D. M. Peehl Antiproliferative and Proapoptotic Activities of Triptolide (PG490), a Natural Product Entering Clinical Trials, on Primary Cultures of Human Prostatic Epithelial Cells Clin. Cancer Res., August 1, 2002; 8(8): 2666 - 2674. [Abstract] [Full Text] [PDF]

				E. C. Goodwin and D. DiMaio Induced Senescence in HeLa Cervical Carcinoma Cells Containing Elevated Telomerase Activity and Extended Telomeres Cell Growth Differ., November 1, 2001; 12(11): 525 - 534. [Abstract] [Full Text] [PDF]

				D. L. Kramer, B.-D. Chang, Y. Chen, P. Diegelman, K. Alm, A. R. Black, I. B. Roninson, and C. W. Porter Polyamine Depletion in Human Melanoma Cells Leads to G1 Arrest Associated with Induction of p21WAF1/CIP1/SDI1, Changes in the Expression of p21-regulated Genes, and a Senescence-like Phenotype Cancer Res., November 1, 2001; 61(21): 7754 - 7762. [Abstract] [Full Text] [PDF]

				D. E. Pritchard, S. Ceryak, L. Ha, J. L. Fornsaglio, S. K. Hartman, T. J. O'Brien, and S. R. Patierno Mechanism of Apoptosis and Determination of Cellular Fate in Chromium(VI)-exposed Populations of Telomerase-immortalized Human Fibroblasts Cell Growth Differ., October 1, 2001; 12(10): 487 - 496. [Abstract] [Full Text] [PDF]

				K. E. Luker, C. M. Pica, R. D. Schreiber, and D. Piwnica-Worms Overexpression of IRF9 Confers Resistance to Antimicrotubule Agents in Breast Cancer Cells Cancer Res., September 1, 2001; 61(17): 6540 - 6547. [Abstract] [Full Text] [PDF]

				C. B. Bennett, J. R. Snipe, J. W. Westmoreland, and M. A. Resnick SIR Functions Are Required for the Toleration of an Unrepaired Double-Strand Break in a Dispensable Yeast Chromosome Mol. Cell. Biol., August 15, 2001; 21(16): 5359 - 5373. [Abstract] [Full Text] [PDF]

				E. VASILE, Y. TOMITA, L. F. BROWN, O. KOCHER, and H. F. DVORAK Differential expression of thymosin {beta}-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis FASEB J, February 1, 2001; 15(2): 458 - 466. [Abstract] [Full Text] [PDF]

				I. A. Davidovich and I. B. Roninson Pleiotropic Resistance to DNA-interactive Drugs Is Associated with Increased Expression of Genes Involved in DNA Replication, Repair, and Stress Response Cancer Res., September 1, 2000; 60(18): 5027 - 5030. [Abstract] [Full Text]

				G. Ferbeyre, E. de Stanchina, E. Querido, N. Baptiste, C. Prives, and S. W. Lowe PML is induced by oncogenic ras and promotes premature senescence Genes & Dev., August 15, 2000; 14(16): 2015 - 2027. [Abstract] [Full Text]

				A. C. Ruth and I. B. Roninson Effects of the Multidrug Transporter P-Glycoprotein on Cellular Responses to Ionizing Radiation Cancer Res., May 1, 2000; 60(10): 2576 - 2578. [Abstract] [Full Text]

				S. W. Lowe and A. W. Lin Apoptosis in cancer Carcinogenesis, March 1, 2000; 21(3): 485 - 495. [Abstract] [Full Text] [PDF]

				D. G. Tang, Y. M. Tokumoto, J. A. Apperly, A. C. Lloyd, and M. C. Raff Lack of Replicative Senescence in Cultured Rat Oligodendrocyte Precursor Cells Science, February 2, 2001; 291(5505): 868 - 871. [Abstract] [Full Text] [PDF]

				B.-D. Chang, M. E. Swift, M. Shen, J. Fang, E. V. Broude, and I. B. Roninson Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent PNAS, January 8, 2002; 99(1): 389 - 394. [Abstract] [Full Text] [PDF]